General MedicationsORALStandard

FLUVOXAMINE MALEATE

Standard Dose

50MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview FLUVOXAMINE MALEATE is listed in Drugs@FDA under application 217917 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient FLUVOXAMINE MALEATE Form and strength TABLET;ORAL - 50MG Sponsor BIONPHARMA Submission history Latest submission status date: 2024-01-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview FLUVOXAMINE MALEATE is listed in Drugs@FDA under application 217917 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FLUVOXAMINE MALEATE Form and strength TABLET;ORAL - 50MG Sponsor BIONPHARMA Submission history Latest submission status date: 2024-01-22 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.